MediLink's TMALIN ADC linker technology: Tumor microenvironment specific extracellular and intracellular double cleavage mechanism for better efficacy and …
用户UpvblTY_VnuA
1天前
15
10
待确认
帖子自动结束时间: 2025-06-01 16:39:10
1. 请及时下载文件确认是否正确, 系统将在 2025-06-03 17:30:34 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
T Xue, L Xiao, Q Liu, S Song, A Shan, X Zhang…
Cancer …, 2024
aacrjournals.org
Antibody-drug conjugates (ADC) are a type of the fastest growing anticancer drug modalities. However, the traditional ADC technologies constrain on therapeutic development, requiring overexpressed targets, high internalizing antigens and efficient intracellular processing. To this end, MediLink
